Sai Life Sciences Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 08:10 pm
06-11-2025 | 08:10 pm
Sai Life Sciences' board approved Q2 & H1 FY26 consolidated results. Q2 revenue hit ₹537.47 Cr, PAT ₹83.84 Cr. H1 revenue reached ₹1,033.89 Cr, PAT ₹144.30 Cr. ₹96.31 Cr from IPO proceeds remains unutilized, temporarily invested.
No comments yet. Be the first to comment!
